Form 4: Velo3D Director Benyamin Buller Sells Shares Under 10b5-1 Trading Plan

Sentiment:

SEC Form 4 Filing


Director Benyamin Buller of Velo3D, Inc. sold a total of 4,000 shares of common stock on March 25 and 26, 2024, under a pre-arranged trading plan.

Summary

  • Benyamin Buller, a director of Velo3D, Inc., sold 2,000 shares of common stock on March 25, 2024, at a weighted average price of $0.5326 per share.
  • The shares were sold in multiple transactions with prices ranging from $0.5002 to $0.5522.
  • Following this transaction, Buller directly owns 5,026,706 shares of Velo3D common stock.
  • On March 26, 2024, Buller sold another 2,000 shares at a weighted average price of $0.5566 per share, with prices ranging from $0.5152 to $0.6067.
  • After the second transaction, Buller directly owns 5,024,706 shares of Velo3D common stock.
  • The sales were executed under a Rule 10b5-1 trading plan adopted on August 15, 2023.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of stock sales by a company director under a pre-arranged trading plan, indicating a neutral sentiment.

Industry Context

Insider sales are a common occurrence, and the use of a 10b5-1 trading plan suggests the sales were pre-planned and not based on any specific non-public information.

Stakeholder Impact

  • The stock sales could create short-term selling pressure on the stock.
  • The sales by a director may be viewed negatively by some investors.

Key Dates

DateDescription
2023/08/15Date of adoption of Rule 10b5-1 trading plan
2024/03/25Date of first stock sale
2024/03/26Date of second stock sale
2024/03/27Date of signature on Form 4

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.